Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum thyroglobulin in differentiated thyroid carcinoma.

U B Ericsson, L Tegler, S Lennquist

    Acta Chirurgica Scandinavica
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cancer risk among women with scoliosis: a nationwide danish register-based study.

    Spine deformity·2026
    Same author

    Genome-wide analysis in 756,646 individuals provides first genetic evidence that <i>ACE2</i> expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease.

    medRxiv : the preprint server for health sciences·2021
    Same author

    Genetic influences on eight psychiatric disorders based on family data of 4 408 646 full and half-siblings, and genetic data of 333 748 cases and controls - CORRIGENDUM.

    Psychological medicine·2018
    Same author

    Genetic influences on eight psychiatric disorders based on family data of 4 408 646 full and half-siblings, and genetic data of 333 748 cases and controls.

    Psychological medicine·2018
    Same author

    Introduction to the third "Focus-on" issue specially devoted to papers within the field of the ESTES section for Disaster and Military Surgery.

    European journal of trauma and emergency surgery : official publication of the European Trauma Society·2016
    Same author

    Editorial.

    European journal of trauma and emergency surgery : official publication of the European Trauma Society·2016

    Serum thyroglobulin (S-Tg) levels can effectively monitor differentiated thyroid carcinoma post-treatment. This blood test offers a reliable alternative to radioactive iodine scans for detecting metastases.

    Area of Science:

    • Endocrinology
    • Oncology
    • Nuclear Medicine

    Background:

    • Differentiated thyroid carcinoma (DTC) management involves monitoring for recurrence.
    • Radioactive iodine (131-I) total body scans are commonly used for detecting metastases.
    • Serum thyroglobulin (S-Tg) is a tumor marker for thyroid cancer.

    Purpose of the Study:

    • To evaluate the utility of serum thyroglobulin (S-Tg) measurements in patients with differentiated thyroid carcinoma.
    • To compare the efficacy of S-Tg levels with 131-I total body scans in detecting metastases.
    • To determine if S-Tg can replace 131-I scans in post-ablative therapy follow-up.

    Main Methods:

    • Serum thyroglobulin (S-Tg) concentrations were measured in 262 patients with differentiated thyroid carcinoma.

    Related Experiment Videos

  • S-Tg levels were analyzed in relation to histology, preoperative and postoperative findings, and during thyroxine treatment.
  • Results were compared with 131-I total body scans and radiological examinations.

    • Main Results:

    • Follicular thyroid carcinoma exhibited the highest S-Tg values.
    • S-Tg levels during thyroxine treatment accurately predicted 131-I scan results in most cases.
    • Patients with metastases generally had S-Tg levels >11 micrograms/l, while those with negative scans had <10 micrograms/l.

    Conclusions:

    • Serum thyroglobulin (S-Tg) determination can replace 131-I total body scans in most patients with differentiated thyroid carcinoma after ablative therapy.
    • S-Tg levels provide a reliable and potentially more convenient method for monitoring disease status.
    • This approach aids in the effective management and follow-up of differentiated thyroid carcinoma patients.